BioCentury
ARTICLE | Company News

Cellectis SA, Serologicals deal

June 6, 2005 7:00 AM UTC

SERO's Celliance Corp. subsidiary will evaluate Cellectis' Meganuclease Recombination System technology for use in developing cell lines. Financial terms were not disclosed. ...